Učitavanje...
A review of the patterns of docetaxel use for hormone-resistant prostate cancer at the Princess Margaret Hospital
BACKGROUND: Based on the tax 327 phase iii trial, docetaxel-based chemotherapy is the standard first-line treatment for hormone-resistant prostate cancer (hrpc); however, there is some heterogeneity in the use of this agent in routine clinical practice. The aim of the present study was to examine th...
Spremljeno u:
| Glavni autori: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Multimed Inc.
2010
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2854632/ https://ncbi.nlm.nih.gov/pubmed/20404974 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|